{"id":"dexamethasone-to-injury-site","safety":{"commonSideEffects":[{"rate":"null","effect":"Adrenal insufficiency"},{"rate":"null","effect":"Cushing's syndrome"},{"rate":"null","effect":"Osteoporosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Dexamethasone works by binding to glucocorticoid receptors, which then translocate to the nucleus and inhibit the transcription of pro-inflammatory genes. This leads to a decrease in the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-alpha, resulting in reduced inflammation and immune suppression.","oneSentence":"Dexamethasone is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting the production of pro-inflammatory cytokines.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:15.111Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of acute injuries"}]},"trialDetails":[{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT04571788","phase":"","title":"Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle","status":"UNKNOWN","sponsor":"Aier School of Ophthalmology, Central South University","startDate":"2019-09-01","conditions":"Rhegmatogenous Retinal Detachment, Surgery","enrollment":150},{"nctId":"NCT03828981","phase":"NA","title":"A Fast-track Versus Conventional Recovery Protocol in Laparoscopic Hysterctomy","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2016-05-31","conditions":"Gynecologic Surgery","enrollment":120},{"nctId":"NCT00257634","phase":"PHASE3","title":"Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2004-12","conditions":"Lateral Epicondylitis, Work Related Injury","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"dexamethasone to injury site","genericName":"dexamethasone to injury site","companyName":"Henry Ford Health System","companyId":"henry-ford-health-system","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting the production of pro-inflammatory cytokines. Used for Treatment of acute injuries.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}